Prelude Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Prelude Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Prelude Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Prelude Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $108k | 75k | 1.44 |
| 2025-06-30 | $58k | 71k | 0.81 |
| 2023-09-30 | $218k | 71k | 3.09 |
| 2023-06-30 | $328k | 73k | 4.50 |
| 2023-03-31 | $271k | 48k | 5.69 |
| 2022-12-31 | $289k | 48k | 6.05 |
| 2022-09-30 | $358k | 54k | 6.61 |
| 2022-06-30 | $191k | 37k | 5.21 |
| 2022-03-31 | $160k | 23k | 6.90 |